Assembly Biosciences is a New York-based biotechnology company dedicated to finding a cure for hepatitis B (HBV) infection, a highly prevalent and devastating infectious disease worldwide, as well as developing novel antivirals for serious viral diseases.
With a passionate commitment to scientific ingenuity and a deep understanding of virology, Assembly Bio aims to make a significant impact on global health by ending the deadly Hepatitis B virus, which claims the lives of over 800,000 individuals annually. Through their ambitious and caring life's work, they strive to change lives and eradicate hepatitis B once and for all.
Generated from the website
